An interventional study of physical activity in Dialysis, sponsored by Centre Hospitalier Intercommunal André Grégoire. Recruiting at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-06-24.
Sponsored by Centre Hospitalier Intercommunal André Grégoire · Not applicable, Interventional, and Other
Dialysis patients have reduced walking capacity and an important risk of high blood pressure. These complications are associated with a decline in quality of life and increased mortality. The hypothesis of the study is to show that physical activity during the dialysis session in dialyzed patients has a benefit on quality of life, as well as on muscle, cardiovascular and dialysis parameters.
Dialysis patients have reduced aerobic capacity, walking ability, and an increased risk of hypertension. These complications are associated with a decline in quality of life and increased mortality.
Since asthenia is too intense after the dialysis session, patients are encouraged to perform physical activity during dialysis sessions. Some studies have shown that physical activity during dialysis can have benefits on quality of life and improve muscle parameters, but without this being clinically significant. Other studies show no benefit. The objective of the study is to explore the benefits of physical activity on quality of life, muscle parameters, and biological and dialysis parameters in a cohort of compliant hemodialysis patients.
Centre Hospitalier Intercommunal André Grégoire is the lead sponsor of 2 studies on the registry; 1 is open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Exercise using the LEMCO Hospital Bed Pedal Exerciser during dialysis.
Other: physical activity
Exercising physical activity during dialysis
Also known as: practice of physical activity during dialysis sessions
Change in the quality of life of patients
Score of the Short Form-36 (SF36) questionnaire. The SF36 score varies from 0 to 100. A low score reflects a perception of poor health, loss of function, and presence of pain. A high score reflects a perception of good health, an absence of functional deficit and pain.
Time frame: 17 weeks
Change in dialysis parameters (KT/V= clearance time/volume)
measurement of clearance time/volume (KT/V)
Time frame: 17 weeks
Change in muscle parameters
Score of the Medical research council scale (MRC)
Time frame: 17 weeks
Change in nutritional parameters
Measurement of body mass index (BMI)
Time frame: 17 weeks
Change in inflammatory parameters
measurement of CRP
Time frame: 17 weeks
Change in lipid profile
Measurement of total cholesterol, LDL cholesterol, HDL cholesterol, triglycerides
Time frame: 17 weeks
Change in blood pressure
Measurement of systolic and diastolic blood pressure
Time frame: 17 weeks
Change in heart rate
measurement of pulse
Time frame: 17 weeks
Change in glycemic control
Levels of albumin
Time frame: 17 weeks
Change in glycemic control
Levels of prealbumin
Time frame: 17 weeks
Plan to share: No
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Centre Hospitalier Intercommunal André Grégoire